Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. | Chief Medical Officer | Common Stock | 47.5K | $2.18M | $45.81 | Sep 3, 2024 | Direct |
Generation Bio Co. | CHIEF MEDICAL OFFICER | Common Stock | 386K | $733K | $1.90 | Jan 29, 2024 | Direct |
Generation Bio Co. | CHIEF MEDICAL OFFICER | Restricted Stock Units | 0 | $0 | $1.91 | Jan 29, 2024 | Direct |
Dyne Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 150K | Sep 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DYN | Dyne Therapeutics, Inc. | Sep 3, 2024 | 2 | $0 | 4 | Sep 3, 2024 | Chief Medical Officer |
DYN | Dyne Therapeutics, Inc. | Sep 3, 2024 | 0 | $0 | 3 | Sep 3, 2024 | Chief Medical Officer |
GBIO | Generation Bio Co. | Jan 29, 2024 | 3 | -$2.8K | 4 | Jan 31, 2024 | CHIEF MEDICAL OFFICER |
GBIO | Generation Bio Co. | Jan 15, 2024 | 6 | -$9.35K | 4 | Jan 17, 2024 | CHIEF MEDICAL OFFICER |
GBIO | Generation Bio Co. | Oct 15, 2023 | 3 | -$7.07K | 4 | Oct 17, 2023 | CHIEF MEDICAL OFFICER |
GBIO | Generation Bio Co. | Jul 15, 2023 | 3 | -$11.1K | 4 | Jul 18, 2023 | CHIEF MEDICAL OFFICER |
GBIO | Generation Bio Co. | Apr 15, 2023 | 3 | -$9.82K | 4 | Apr 18, 2023 | CHIEF MEDICAL OFFICER |
GBIO | Generation Bio Co. | Jan 20, 2023 | 2 | $0 | 4 | Jan 24, 2023 | CHIEF MEDICAL OFFICER |
GBIO | Generation Bio Co. | Jan 15, 2023 | 3 | -$13.1K | 4 | Jan 18, 2023 | CHIEF MEDICAL OFFICER |
GBIO | Generation Bio Co. | Oct 15, 2022 | 3 | -$12.3K | 4 | Oct 18, 2022 | CHIEF MEDICAL OFFICER |
GBIO | Generation Bio Co. | Jul 15, 2022 | 3 | -$31.4K | 4 | Jul 19, 2022 | CHIEF MEDICAL OFFICER |
GBIO | Generation Bio Co. | Jan 21, 2022 | 2 | $0 | 4 | Jan 25, 2022 | CHIEF MEDICAL OFFICER |
GBIO | Generation Bio Co. | Jul 8, 2021 | 4 | -$70.5K | 4 | Jul 12, 2021 | CHIEF MEDICAL OFFICER |